The Source for Neurovascular News and Education

September 21, 2020


More study on prevention and treatment strategies for this devastating complication is the next step, one expert contends.

 

Malignant brain edema has a substantial negative impact on the outcomes of mechanical thrombectomy, according to a study published online recently ahead of print in the Journal of NeuroInterventional Surgery. Internal carotid artery (ICA) occlusions and poor collaterals were identified as predictors of the complication.

 

Increasing understanding of how thrombectomy may relate to malignant brain edema is important in light of recent efforts to expand the population of stroke patients who may benefit from this intervention, W. Taylor Kimberly, MD, PhD (Harvard Medical School and Massachusetts General Hospital, Boston, MA), who was not involved in the study, told Neurovascular Exchange. The risk that thrombectomy may contribute to brain edema, he added, is of particular concern in patients with low ASPECTS scores.

 

The new study, Kimberly commented, is “an important piece to the puzzle in terms of understanding relationship of thrombectomy and edema. Previously, there have been conflicting reports in the literature. Some suggest that thrombectomy or reperfusion can lead to worsening edema. Other studies have suggested that thrombectomy or reperfusion can reduce edema.” Notably, this study focused solely on the thrombectomy population, he pointed out.

 

Edema ‘Leverages a Severe Penalty’ on Recovery

 

Xianjun Huang, MD (Yijishan Hospital of Wannan Medical College, Wuhu, China), and colleagues evaluated 130 consecutive patients (mean age 68.6 years; 50% male) who underwent mechanical thrombectomy for anterior circulation large-vessel occlusion stroke. Of these patients, 26.9% developed malignant brain edema, defined as a midline shift of ≥ 5 mm on follow-up imaging within 72 hours after thrombectomy.

 

Overall, 80% of patients attained an mTICI score of 2b-3. Among these patients, 23.1% went on to develop malignant brain edema. After controlling for confounders, predictors of malignant brain edema were identified as the presence of ICA occlusions and collateral status.

 

Predictors of Malignant Brain Edema

 

OR (95% CI)

P Value

ICA Occlusion

3.75 (1.17-12.01)

0.026

Collateral Score Grade 1 vs 0

0.73 (0.19-2.75)

0.638

Collateral Score Grade 2 vs 0

0.13 (0.02-0.82)

0.030

 

Patients who developed malignant brain edema were less likely to develop functional independence, defined as an mRS 0-2 (OR 7.83; 95% CI 1.73-35.43). They also had a significantly greater 90-day mortality rate (OR 7.96; 95% CI 2.27-27.85) than patients without this complication.

 

“Thrombectomy is now the standard of care, but . . . if a patient develops brain edema, it really leverages a severe penalty on their recovery,” said Kimberley. “This means there is still room for additional strategies and interventions to help patients recover from a stroke.”

 

Being able to predict who might develop severe edema, he continued, is useful clinically because “it can help guide decisions around decompressive craniectomy and upcoming or future management of edema in a given patient,” he explained.

 

Medical and surgical strategies for the prevention and treatment malignant brain edema are currently being evaluated. This is an area of research in which Kimberley himself is active.

 

He noted that this study is retrospective and only included thrombectomy patients. “Ideally to answer this question, it would be a comparison [with] a control or nonthrombectomy patient population,” Kimberly suggested. “The authors acknowledge that as a limitation, and there are randomized controlled trials to address this question that are underway.”

 

 


Source:

Huang X, Yang Q, Shi X, et al. Predictors of malignant brain edema after mechanical thrombectomy for acute ischemic stroke. J NeuroInterv Surg. 2019;Epub ahead of print.

 

Disclosures:

  • Huang reports no relevant conflicts of interest.
  • Kimberley reports receiving research funding from Biogen.

 

Tuesday, July 21 2020

Whether COVID-19 adds risk by virtue of being a comorbidity or due to direct effects is unknown. A...

Read More »

Friday, May 8 2020

In some cases, large strokes are the first presentation of COVID-19 in younger patients, but...

Read More »

Monday, April 6 2020

Clopidogrel added to rivaroxaban and aspirin increased bleeding with no added protection from limb or...

Read More »

Monday, April 6 2020

Although rivaroxaban patients had more bleeding, the events were not severe and none were...

Read More »

Monday, April 6 2020

The strokes do not appear related to valve thrombosis or structural degeneration, but rather to...

Read More »

Thursday, January 23 2020

A fundamental unanswered question is whether any type of oral anticoagulation is needed in the...

Read More »

Monday, January 6 2020

Though periprocedural results look good, there are some questions about its rapid rise when...

Read More »

Wednesday, August 21 2019

In addition, an infarct in a new territory did not emerge as an independent predictor of...

Read More »

Wednesday, August 21 2019

The procedure—a hybrid of surgical and endovascular techniques—offers low stroke rates and a short...

Read More »

Wednesday, August 21 2019

Hyperintense acute reperfusion marker on MRI portends worse outcomes and may help identify...

Read More »

Wednesday, August 21 2019

The prematurely stopped and underpowered trial failed to meet its primary endpoint but was...

Read More »

Wednesday, August 21 2019

But an outside source questioned the decision to lump CREST together with EVA-3S, SPACE, and ICSS.

Read More »